SIROLIMUS
Phase 2 small_molecule active
Quick answer
SIROLIMUS for Adult patients (men and women) (≥ 18 years of age) with cutaneous sarcoidosis involving the face is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Adult patients (men and women) (≥ 18 years of age) with cutaneous sarcoidosis involving the face
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active